Raja Khuri, MD, Joins Winship Cancer Institute Faculty
Fadlo Raja Khuri,
MD, has been named Associate Director for Clinical and Translational
Research for The Winship Cancer Institute (WCI) at Emory University.
Dr. Khuri joins WCI from
The University of Texas M.D. Anderson Cancer Center in Houston, Texas,
where he served as associate professor of Medicine and chief, Section
of Molecular Therapeutics and Chemoprevention, Department of Thoracic/Head
and Neck Medical Oncology.
In his position as Associate
Director for Clinical and Translational Research, Dr. Khuri will oversee
the coordination of basic science research with clinical application
throughout the WCI.
"We are very excited that
Dr. Khuri is joining our faculty at Winship and at Emory," said Dr.
Jonathan Simons, director of WCI. "He is an internationally recognized
investigator who will contribute greatly to our mission of translating
groundbreaking cancer research into comprehensive care for cancer patients
and their families."
Author of more than 100 peer-reviewed
and invited journal articles, Dr. Khuri also has been the principal
and co-principal investigator for numerous clinical trials. Currently,
Dr. Khuri serves as the principal investigator for five National Cancer
Institute-funded clinical trials.
Dr. Khuri earned his doctoral
degree from Columbia University College of Physicians and Surgeons,
New York, and is certified by the American Board of Internal Medicine.
For three consecutive years Dr. Khuri received the American Cancer Society
Clinical Oncology Career Development Award and the M.D. Anderson Faculty
Excellence Award. Dr. Khuri is an active member of the American College
of Physicians, the American Association for Cancer Research and the
American Society of Clinical Oncology. In addition, he serves as chairman
for the chemoprevention committee for the Radiation Therapy Oncology
Group and as a member of the American Association for Cancer Research
and the American Society of Clinical Oncology.
Dr. Khuri serves as an associate
editor for Clinical Cancer Research, and periodically conducts
reviews for a variety of medical journals, including: British Journal
of Cancer, Cancer, Cancer Epidemiology, Biomarkers and Prevention, Cancer
Research, Clinical Cancer Research, European Journal of Oncology, Head
and Neck, International Journal of Oncology, Journal of Clinical Oncology,
Journal of the National Cancer Institute and the International Journal
of Radiation Oncology, Biology, Physics.